Investor Insights from CEOs & CFOs | Financial Results & Presentations | seat11a

Wacker Chemie AG ESG: Key Takeaways

Discover Wacker Chemie AG’s Innovative Approach in the Chemical Industry

Explore the ingenious tactics and strategies implemented by Wacker Chemie AG in this comprehensive video presentation directed by Joerg Hoffmann, IR. Gain insights into the company’s history operational strategies, and pivot towards sustainability and profitability within the global chemical sector.

Immerse yourself in the fundamental practices and strategic foresight of Wacker Chemie AG. Learn how their unwavering commitment to sustainable products and streamlined processes is actively moulding the future trajectory of the global chemical industry.

Engage with the intricacies of Wacker Chemie AG’s plan by diving into its five strategic pillars designed to assure sustained growth and stability within the volatile chemical industry.

Delve into how increasing production volumes and capabilities form a critical aspect of Wacker Chemie AG’s long-term strategic orientation.

Explore the tactical initiatives propelling Wacker Chemie AG to surpass industry growth averages, securing its position as a leader in the chemical domain.

Understand the financial and operational strategies employed by Wacker Chemie AG to secure attractive profit margins amidst industry challenges and competition.

Learn how Wacker Chemie AG is intricately weaving sustainability into its core operational frameworks, ensuring an ecologically responsible trajectory for its global operations.

Discover how Wacker Chemie AG ensures a steady and growing cash inflow through adept management and strategic oversight of its operational activities.

Engaging in Wacker Chemie AG’s Sustainability and ProfitabilityWacker Chemie AG’s Strategic Goals for a Progressive FutureExpanding Production CapacitiesGrowing Faster Than the Industry AverageAchieving Attractive MarginsEmphasising SustainabilityIncreasing Cash Inflow from Operating Activities

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

In this informative video presentation, Christian Ludwig, IR at DEUTZ AG, a leading global provider of off-highway diesel and gas engines, discusses the company’s commitment to Environmental, Social, and Governance (ESG) initiatives.

DEUTZ AG has a diverse portfolio of products, including liquid-cooled engines with capacities up to 8 litres and air-cooled engines exceeding 8 litres.

Additionally, DEUTZ AG is dedicated to electrifying drive systems, such as the Torqeedo brand electric drives for boats.

The company serves various industries, including construction, agriculture, material handling, stationary equipment, rail vehicles, etc.

Learn about DEUTZ AG’s history, product offerings, and comprehensive approach to ESG practices as they innovate and create value for their stakeholders.

DEUTZ AG: Diverse and InnovativeElectrifying Drive SystemsIndustries Served by DEUTZ AGHistory, Offerings, and ESG Practices

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Hypoport SE FY 2021: Key Takeaways

Comprehensive Financial Report: Hypoport SE’s Impressive Performance in FY 2021

In this comprehensive financial report video, Hypoport SE’s CEO, Ronald Slabke, articulately outlines the firm’s outstanding performance in FY 2021. The video starts with an introduction, spotlighting an elaborate revenue breakdown by various business segments and accentuating the firm’s diversified earning channels.

The CEO delves into the Credit Platform segment, discussing its operational efficiency and substantial contributions to its overall revenue. The section emphasises the high growth potential of Europace, highlighting its anticipated role as the future powerhouse of Hypoport SE. Viewers are offered an insightful analysis of the digitalisation trend within the credit industry and how Hypoport SE positions itself at the pinnacle of this thrilling development.

In the ‘REM Capital: Extremely Strong Year’ segment, Ronald Slabke elucidates the business’s stellar performance and outlines steps to safeguard future growth. Moreover, the video explores the significant growth experienced by the company across all segments, with Dr. Klein reporting a robust sales volume and Private Clients achieving a new record.

In the ‘Overview Core KPIs’ section, CEO Ronald Slabke deciphers the key performance indicators that gauge the company’s success. He also underscores Hypoport’s longstanding track record of consistently delivering robust shareholder returns.

The video concludes with a section on ‘Investments in Further Growth,’ wherein the CEO shares insights on future growth strategies. This includes alluding to the measures Hypoport SE implements to ensure sustained growth and prosperity in the forthcoming financial year.

Credit Platform SegmentREM Capital: A Year of Exceptional StrengthCore KPIs OverviewInvesting in Future Growth

Comprehensive Presentation on DEUTZ AG’s Financial Results for FY-2021

In this comprehensive presentation, Christian Ludwig, Investor Relations representative at DEUTZ AG, discusses the company’s financial results for FY-2021.

Starting with an introduction to DEUTZ’s business segments, including DEUTZ Compact Engines, DEUTZ Customized Solutions, and the Other segment, he covers key operational and strategic developments.

Christian highlights positive and negative factors influencing DEUTZ’s performance and elaborates on the company’s sustainability strategy and strategic roadmap.

The video delves into the 2021 financial results, focusing on continued earnings improvement, R&D, capital expenditure, working capital, cash flow, and net financial position.

Lastly, Christian emphasises DEUTZ’s rock-solid balance sheet and guides for 2022.

Introduction to DEUTZ’s Business SegmentsOperational and Strategic DevelopmentsDetailed Insight into the 2021 Financial ResultsContinuous Earnings Improvement and Key Financial AreasLooking Forward: DEUTZ’s Financial Guidance for 2022Emphasising the Rock-Solid Balance Sheet

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Wacker Chemie AG FY 2021: Key Takeaways

Exploring Wacker Chemie AG’s Financial Triumph in FY-2021

Discover Wacker Chemie AG’s impressive FY-2021 financial performance and future outlook in this comprehensive presentation.

Joerg Hoffmann, in Investor Relations, expertly navigates through the company’s key achievements, presenting a record-breaking dividend proposal and shedding light on the sustainability targets and segment analysis that underscore Wacker Chemie AG’s operational and strategic prowess.

Gain critical insights into their P/L statement, balance sheet, and net financial position, coupled with a Q1 trading update, setting the stage for a robust and promising FY-2022.

Wacker Chemie AG transparently shares its profit/loss statement and balance sheet, presenting a firm net financial position as a foundation for future strategic initiatives and investments.

Embark on a journey through the Q1 trading update and explore forecasts and strategic movements poised to shape Wacker Chemie AG’s operations and financials in FY-2022.

Key Achievements and Future Projections Presented by Joerg HoffmannFinancial Insights and Strategies for FY-2022Detailing P/L Statement, Balance Sheet, and Net Financial PositionQ1 Trading Update and Anticipated Movements in FY-2022

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

In today’s podcast, we are presenting Vincenzo Moccia, CEO and Antonello Sannia, Scientific Chief of Igea Pharma NV

They will provide a quick update on the Elevator Pitch of Igea Pharma:

Company Overview - Vincenzo Moccia, CEO

Products - Antonello Sannia, Scientific Chief

----------------------------

▶️ Visit us: https://seat11a.com/

----------------------------

Company Profile:

IGEA Pharma NV (IGEA) is a Holding Company listed on the SIX Zurich Swiss Exchange with Headquarters in the Netherlands

IGEA has recently completed a business combination with Blue Sky Natural Resources Ltd (BSNR).

IGEA is a life sciences business and offers medical testing devices and dietary supplements. The company's focus is on products and services related to the prevention of Alzheimer's disease and Diabetes Type II.

BSNR is a UK based holding company which has a 50% equity interest in Blue Sky Swisse SA (BSS), a company developing a supercritical CO2 extraction business for the CBD market serving the wellness, food & beverage and nutraceutical industries.

On April 28th the Igea extraordinary general meeting approved the resolution of the Board to enter the business combination with BSNR. On the 29th of June Igea BOD resolved to launch the offer to BSNR and issue up to a maximum of 309'600'000 new shares (with an exchange ratio 1:9) reserved for allotment to the shareholders of BSNR in exchange for the contribution in-kind of their shares of BSNR.

On July 9th the GSM of Igea resolved to change the name of the combined entity to “IGEA Pharma NV”

The transaction was effective on 23rd September 2021

----------------------------

▶️ Visit us: https://seat11a.com/

----------------------------

▶️ Other videos:

Elevator Pitches: https://seat11a.com/media-type/elevator-pitch/

Company Presentations: https://seat11a.com/media-type/presentation/

Financial Results: https://seat11a.com/media-type/financials/

The Big Conversations: https://seat11a.com/media-type/conversation/

ESG Topics: https://seat11a.com/media-type/esg/

Product Highlights: https://seat11a.com/media-type/products/

-----------------------------

▶️ About seat11a:

Seat11a is the next-generation roadshow for listed companies. We democratize financial intelligence by offering listed companies an investor video platform to address their message to Institutional and Professional Investors anywhere, anytime.

-----------------------------

▶️ For business inquiries: [email protected]

-----------------------------

Disclaimer:

This publication is just for informational purposes only!

it is not considered to give any investment advice! 

You agree to www.seat11a.com/legal/ and www.seat11a.com/imprint/

AIXTRON SE FY 2021: Key Takeaways

Discover AIXTRON SE’s Financial Performance in FY-2021 and their Exciting Future OutlookInnovation and Global Presence in the Semiconductor Industry

As a leading provider of deposition equipment to the semiconductor industry, AIXTRON SE has been pushing the boundaries of innovation since its inception in 1983. The company’s global presence has enabled manufacturers to create cutting-edge electronic and optoelectronic components for various applications and industries.

In this comprehensive video presentation, Guido Pickert, Investor Relations representative for AIXTRON SE, delves into the company’s financials for the fiscal year 2021.

Pickert covers essential financial aspects throughout this detailed analysis, including income statements, balance sheets, and cash-flow statements. He also sheds light on the company’s guidance for 2022 and its 24-month development outlook. Moreover, the presentation explores revenue analysis, EU-Taxonomy & ESG implications.

It showcases the company’s versatile product range, including customer-specific systems for high-volume manufacturing and R&D or pilot production.

AIXTRON’s cutting-edge deposition technologies, such as MOCVD, PECVD, PVPD, and OVPD, have allowed them to create a diverse portfolio of advanced power and optoelectronic devices. With a focus on increasing processing speed, energy efficiency, and cost reduction, AIXTRON SE is well-positioned for continued growth in the semiconductor industry.

Comprehensive Financial Analysis by Guido PickertDetailed Insight into Essential Financial AspectsExploring AIXTRON’s Versatile Product RangeTechnological Advancements and Portfolio Diversity

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Discover how AIXTRON SE Shapes the Future of Electronic and Optoelectronic ApplicationsGuido Pickert Discusses AIXTRON SE’s Profile and Innovative Technologies

In this detailed presentation, Guido Pickert, Investor Relations, discusses the company’s profile, innovative technologies, and the growing demand for its products in various industries.

Learn how AIXTRON’s deposition technologies like MOCVD, PECVD, PVPD, and OVPD are revolutionising industries such as Laser and LED, display, data transmission, and power management, while aligning with EU Taxonomy and ESG guidelines.

Revolutionising Industries with AIXTRON’s Deposition Technologies

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

Media and Games FY 2021: Key Takeaways

Join Paul Echt for a Deep Dive into MGI’s Financial Performance

Join Paul Echt, CFO of Media and Games Invest SE, as he delves into the company’s remarkable financial performance in FY-2021.

Discover MGI’s key facts, global reach, and major Q4 events that led to their continuous, strong, profitable growth with a revenue CAGR of 76% since 2018.

Learn about the company’s successful acquisition strategy, integrating over 30 companies and assets in the past 6 years, and how they leverage cloud technology for efficiency and competitive advantages.

Get insights into MGI’s growth KPIs, cost structure, operating cash flow, and capex, as well as a comparison between their actual vs guidance for 2021 and their outlook for 2022.

Don’t miss this comprehensive review of a leading digital integrated games and media company listed on the Nasdaq First North Premier Growth Market and Frankfurt Stock Exchange.

Discover MGI’s Key Facts and Significant Q4 EventsMGI’s Successful Acquisition StrategyInsights into MGI’s Growth KPIs and Financial StructureComprehensive Review of a Nasdaq and Frankfurt-Listed Company

https://seat11a.com/investor-relations-elevator-pitch/

Company Presentation: https://seat11a.com/investor-relations-company-presentation/

Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/

Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/

ESG Presentation: https://seat11a.com/investor-relations-esg/

T&C

This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

BRAIN Biotech AG Elevator Pitch: Key Takeaways

Q1-2022 Financials and Insights
Michael Schneiders, Investor Relations, presents an in-depth overview of BRAIN Biotech AG’s group structure, strategic deals, advanced technology, and financial highlights. Key topics include the Breatec deal, PHA 121, the SolasCure partnership, and the innovative BEC patent. Discover the company’s long-term revenue growth trajectory and their strategies for addressing Covid-19, supply chain disruptions, and inflation.

Guidance and Mid-Term Targets
BRAIN Biotech AG continues to focus on innovation and development of bio-based products and solutions for nutrition, health, and the environment. Learn about their guidance and mid-term targets for sustained growth.

BRAIN Group’s Diverse Collection and Global Presence
The BRAIN Group leverages its extensive Bioarchive, consisting of microorganisms, genetic material, and natural substances. With production facilities in Germany, the UK, and the US, BRAIN integrates its biotechnological production expertise to address technological challenges and develop bio-based products used across industries.

Commitment to Global Standards and Societal Goals
As a participant in the United Nations Global Compact, BRAIN Biotech AG aligns its strategies with universal principles of human rights, labor, environment, and anti-corruption, actively contributing to societal goals.

Stock Market Presence Since IPO in 2016
Listed in the Prime Standard of the Frankfurt Stock Exchange since its IPO in 2016 (ISIN DE000520394), BRAIN Biotech AG remains a key player in the biotech industry.

Other videos:

T&C: This publication is for informational purposes only and does not constitute investment advice. By using this website, you agree to our terms and conditions outlined on ⁠www.seat11a.com/legal⁠ and ⁠www.seat11a.com/imprint⁠.